24-hr Intraocular Pressure Control With Brinzolamide 1% / Brimonidine 0.2% Ophthalmic Suspension vs Vehicle
Phase of Trial: Phase IV
Latest Information Update: 28 Jan 2018
At a glance
- Drugs Brimonidine/brinzolamide (Primary)
- Indications Ocular hypertension; Open-angle glaucoma
- Focus Therapeutic Use
- Sponsors Alcon
- 18 Jan 2017 Status changed from active, no longer recruiting to completed.
- 25 Nov 2016 Status changed from recruiting to active, no longer recruiting.
- 24 May 2016 Status changed from not yet recruiting to recruiting.